Effects of Prostadyn Sabale Capsules on Chronic Prostatitis

Tianpeng Wu,Xiaobin Zhang,Rongyang Wu,Xiuheng Liu
DOI: https://doi.org/10.3969/j.issn.1009-3591.2004.05.005
2004-01-01
Abstract:OBJECTIVE:To study the effects of prostadyn sabale capsules on chronic prostatitis (CP).METHODS:One hundred and twenty-five CP cases were divided into three categories according to National Institutes of Health (NIH) concensus definition and classification of CP:31 of category II. 75 of category IIIA and 19 of category IIIB. All the cases were treated with prostadyn sabale capsules at the dosage of 320 mg twice a day. NIH chronic prostatitis symptom index (NIH-CPSI), routine examination and culture of expressed prostatic secretions (EPS) were prospectively evaluated before and after treatment.RESULTS:The cure rates of category II, category IIIA and category IIIB were 25.8%, 16.0%, and 21.1% respectively, the general cure rate being 19.2%. The alleviation rate was 63.5% and the total effectivity rate was 82.7%. No side effects were observed.CONCLUSIONS:Prostadyn sabale capsules have good effects on CP.
What problem does this paper attempt to address?